ReviewWorld journal of microbiology & biotechnology2025
Industrial applications of Phanerochaete chrysosporium lignin-degrading enzymes: current status, production challenges, and future directions.
Review in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Characterization and Genome Analysis ofJournal of fungi (Basel, Switzerland) · 2025Article
- High-Yield Vanillin Production Through RSM-Optimized Solid-State Fermentation Process from Brewer's Spent Grains in a Single-Use Bag Bioreactor.Molecules (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Phanerochaete chrysosporium (Pc) is a white-rot fungus recognized for its highly efficient lignin-degrading enzymes (LDEs), including lignin peroxidase (LiP), manganese peroxidase (MnP), and laccase. These oxidative enzymes possess transformative capabilities across multiple industrial applications, such as biopulping, biofuel production, bioremediation and for the treatment of industrial wastewater. However, the commercial use of these enzymes is limited due to time-consuming scale-up procedures in native hosts, instability in industrial environments, and high production costs. The recent developments in recombinant expression systems, particularly those employing microbial and plant platforms provide promising opportunities to enhance enzyme yield, stability, and reduce the cost. Despite these advancements, significant challenges remain, which include the formation of inclusion bodies, the need for nutrient and co-factor supplementation, and the development of effective purification strategies. Modern advancements in protein engineering, such as site-directed mutation and in silico approaches, may hold significant promise in addressing the challenges posed by pH optimization, which is prominent in wild-type enzymes. This review examines the current industrial applications of P. chrysosporium ligninolytic enzymes, highlights production bottlenecks in several hosts, and discusses the strategies to enhance their commercial viability of these enzymes.
Indexed as
Identifiers
40341513What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.